Anti-MPO SM2Z9671G

GUDID 00845533002325

The Anti-Myeloperoxidase (MPO) Test System is intended for the qualitative and semi-quantitative detection of IgG-class antibody to myeloperoxidase in human serum. This test is intended to be used as an aid in the diagnosis of various autoimmune vasculitis disorders characterized by elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA). MPO-ANCA may be associated with autoimmune disorders such as Wegener’s granulomatosis, ICGN, MPA and PRS. This test is for In Vitro diagnostic use.

ZEUS SCIENTIFIC, INC.

Myeloperoxidase (MPO) IVD, kit, enzyme immunoassay
Primary Device ID00845533002325
NIH Device Record Key34c22ad5-e5b1-4c64-bd2e-433f48288caa
Commercial Distribution StatusIn Commercial Distribution
Brand NameAnti-MPO
Version Model NumberSM2Z9671G
Catalog NumberSM2Z9671G
Company DUNS080953946
Company NameZEUS SCIENTIFIC, INC.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100845533002325 [Primary]

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2025-12-17
Device Publish Date2025-12-09

On-Brand Devices [Anti-MPO]

00845533002325The Anti-Myeloperoxidase (MPO) Test System is intended for the qualitative and semi-quantitative
00845533002318The Anti Myeloperoxidase (MPO) is intended for the qualitative and semi-quantitative detection o

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.